好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease: ADAPT-PD clinical trial methodology and early data
Movement Disorders
P1 - Poster Session 1 (8:00 AM-9:00 AM)
5-002
To describe the design and early data from the pivotal Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) clinical trial (NCT04547712).
In pilot studies, adaptive deep brain stimulation (aDBS) has been associated with greater motor symptom control, fewer side effects, and lower total electrical energy delivered (TEED) compared to continuous DBS (cDBS).
The ADAPT-PD study is a multicenter, prospective, single-blind, randomized crossover clinical investigation evaluating the safety and effectiveness of aDBS for Parkinson’s disease (PD). The study includes a cohort without (primary cohort) and with directional stimulation (directional cohort). Participants have globus pallidus pars interna or subthalamic nucleus DBS leads connected to a Medtronic PerceptTM PC DBS device capable of sensing local field potentials (LFPs). An investigational feature is unlocked to allow programming of two different aDBS modes using low frequency (8-30 Hz) LFP control signals. The study consists of four phases following enrollment: cDBS Baseline, aDBS Setup and Adjustment, aDBS Evaluation, and Long-term Follow-up. Randomized, single-blinded crossover to aDBS in a single or dual-threshold mode is executed in participants with an acceptable response to either or both aDBS modes.
The clinical trial is ongoing with 12 centers activated and 10 sites which have enrolled a primary cohort of 68 and a directional cohort of 17. Demographic and preliminary data will be featured at the time of presentation. Primary endpoint is the equivalence of aDBS to cDBS for ON time without troublesome dyskinesia. Other endpoints are TEED, motor assessments from a wearable device, Voice Handicap Index, MDS-UPDRS, EQ-5D-5L, PDSS-2, PDQ-39, and patient preference. Safety measures include stimulation-related adverse events (AEs), other AEs, and device deficiencies.
This pivotal clinical study of aDBS in a clinical and home setting is expected to generate data to assess the safety and effectiveness for aDBS in PD.
Authors/Disclosures
Todd Herrington, MD (Massachusetts General Hospital)
PRESENTER 		Dr. Herrington has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic, Inc. Dr. Herrington has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MarvelBiome. Dr. Herrington has received personal compensation in the range of $0-$499 for serving as an Expert Witness for CRICO. The institution of Dr. Herrington has received research support from NIH/NINDS (K23NS099380).
Helen Bronte-Stewart, MD, MSE (Stanford Neurology) Dr. Bronte-Stewart has stock in QDG Health. Dr. Bronte-Stewart has received intellectual property interests from a discovery or technology relating to health care.
Martijn Beudel, MD, PhD (Amsterdam University Medical Centers) Dr. Beudel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Jill L. Ostrem, MD, FAAN (UCSF) Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Superness. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcureX. Dr. Ostrem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Ostrem has received research support from Neuroderm. The institution of Dr. Ostrem has received research support from Boston Scientific. The institution of Dr. Ostrem has received research support from Medtronic. The institution of Dr. Ostrem has received research support from Rune.
Alfonso Fasano, MD, PhD, FAAN (Toronto Western Hospital - U of Toronto) Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Leonardo Almeida (University of Florida College of Medicine - Neurology) No disclosure on file
Travis J. Hassell, MD, PhD (Indiana University School of Medicine) No disclosure on file
Elena Moro, MD, FAAN (Grenoble Alpes University) Dr. Moro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Moro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Moro has received research support from Abbott. The institution of Dr. Moro has received research support from Medtronic.
Michal T. Gostkowski, DO (Cleveland Clinic) The institution of Dr. Gostkowski has received research support from Medtronic.
Kyle T. Mitchell, MD (Duke University Movement Disorders Center) Dr. Mitchell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Mitchell has received research support from Medtronic. The institution of Dr. Mitchell has received research support from Deep Brain Innovations. The institution of Dr. Mitchell has received research support from National Institutes of Health. The institution of Dr. Mitchell has received research support from National Institute on Aging.
No disclosure on file
Nagaraja Sarangmat (Oxford University Hospital NHS foundation trust) Nagaraja Sarangmat has nothing to disclose.
Scott Stanslaski (Medtronic) Scott Stanslaski has received personal compensation for serving as an employee of Medtronic. Scott Stanslaski has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Medtronic. Scott Stanslaski has stock in Medtronic. Scott Stanslaski has received intellectual property interests from a discovery or technology relating to health care. Scott Stanslaski has received personal compensation in the range of $100,000-$499,999 for serving as a Engineer with Medtronic.
Lisa Tonder Lisa Tonder has received personal compensation for serving as an employee of Medtronic. An immediate family member of Lisa Tonder has received personal compensation for serving as an employee of Medtronic.
Rebekah L. Summers, PhD, PT (Medtronic) Rebekah Summers has received personal compensation for serving as an employee of Medtronic. Rebekah Summers has received research support from National Institute of Health.
Robert S. Raike, PhD (Medtronic Neuromodulation Research) Dr. Raike has received personal compensation for serving as an employee of Medtronic. Dr. Raike has received intellectual property interests from a discovery or technology relating to health care.